Elanco Animal Health Inc (ELAN)

Schlusskurs vom Vortag:

$13.47

Offen:

$13.73

24-Stunden-Volumen:

3.29M

Marktkapitalisierung:

$6.69B

Einnahmen:

$4.42B

Nettoeinkommen (Verlust:

$-1.23B

KGV:

-67.65

EPS:

-0.2

Netto-Cashflow:

$117.00M

1W Leistung:

+2.04%

1M Leistung:

-12.31%

6M Leistung:

+40.79%

1J Leistung:

+48.03%

1-Tages-Spanne:

$13.41

$13.77

52-Wochen-Spanne:

$7.88

$16.88

Elanco Animal Health Inc Stock (ELAN) Company Profile

Firmenname

Elanco Animal Health Inc

Sektor

Healthcare (1213)

Branche

Drug Manufacturers - Specialty & Generic (3)

Telefon

877-352-6261

Adresse

2500 Innovation Way, Greenfield

Mitarbeiter

5,590

Twitter

@Elanco

Nächster Verdiensttermin

2024-05-08

Neueste SEC-Einreichungen

ELAN's Discussions on Twitter

Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-01-05	Hochstufung	Stifel	Hold → Buy
2023-12-19	Eingeleitet	Jefferies	Buy
2023-12-15	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2023-12-07	Eingeleitet	Exane BNP Paribas	Outperform
2023-04-20	Hochstufung	Barclays	Equal Weight → Overweight
2022-08-18	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2022-08-16	Herabstufung	JP Morgan	Overweight → Neutral
2022-07-21	Herabstufung	Goldman	Buy → Sell
2022-07-12	Eingeleitet	Piper Sandler	Neutral
2021-11-18	Eingeleitet	Morgan Stanley	Overweight
2021-10-28	Herabstufung	Stifel	Buy → Hold
2021-08-05	Fortgesetzt	Credit Suisse	Outperform
2021-06-15	Hochstufung	Cleveland Research	Underperform → Neutral
2021-05-11	Hochstufung	Barclays	Underweight → Equal Weight
2021-05-11	Hochstufung	Gabelli & Co	Hold → Buy
2021-04-15	Eingeleitet	Stifel	Buy
2021-03-22	Herabstufung	Gabelli & Co	Buy → Hold
2021-02-26	Hochstufung	Credit Suisse	Neutral → Outperform
2020-12-09	Herabstufung	Argus	Buy → Hold
2020-11-09	Herabstufung	Barclays	Overweight → Underweight
2020-08-20	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2020-08-13	Fortgesetzt	Credit Suisse	Neutral
2020-08-04	Fortgesetzt	Goldman	Buy
2020-07-27	Herabstufung	Cleveland Research	Neutral → Underperform
2020-04-02	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2020-01-10	Eingeleitet	Raymond James	Mkt Perform
2019-12-19	Hochstufung	BofA/Merrill	Neutral → Buy
2019-11-07	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2019-09-23	Eingeleitet	Barclays	Overweight
2019-08-26	Herabstufung	BofA/Merrill	Buy → Neutral
2019-08-15	Hochstufung	UBS	Sell → Neutral
2019-05-23	Eingeleitet	Guggenheim	Neutral
2019-03-18	Hochstufung	BofA/Merrill	Neutral → Buy
2019-03-13	Fortgesetzt	Morgan Stanley	Equal-Weight
2019-02-12	Eingeleitet	William Blair	Mkt Perform
2019-01-23	Eingeleitet	UBS	Sell
2019-01-15	Eingeleitet	Argus	Buy
2018-10-15	Eingeleitet	Morgan Stanley	Equal-Weight

Alle ansehen

Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten

Breaking Down Elanco Animal Health: 6 Analysts Share Their Views

Benzinga

Elanco Animal Health (ELAN) Q4 2023 Earnings Call Transcript

The Motley Fool

Here's What Key Metrics Tell Us About Elanco Animal Health Incorporated (ELAN) Q4 Earnings

Zacks Investment Research

US Stocks Could Pause For Breather After Record Rally: Analyst Says 'No Doubt' That 2024 Shaping Up To 'Best Year Since 1999'

Benzinga

Analysts Estimate U.S. Physical Therapy (USPH) to Report a Decline in Earnings: What to Look Out for

Zacks Investment Research

Elanco Animal Health Incorporated (ELAN) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Zacks Investment Research

Finanzdaten der Elanco Animal Health Inc-Aktie (ELAN)

Elanco Animal Health Inc (ELAN) Umsatz 2024

Elanco Animal Health Inc (ELAN) Nettogewinn 2024

Elanco Animal Health Inc (ELAN) Free Cashflow 2024

Elanco Animal Health Inc (ELAN) Gewinn je Aktie 2024